Intensified Treatment With Carfilzomib in Myeloma Patients Still PET-positive After First Line Treatment.
Clinical trial NCT03314636 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03314636
- Sponsor
- Oslo University Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-16
- Primary completion
- 2021-11-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.